|星空彩票电脑版
%A FENG Hui-li,WANG Peng-wen %T %0 Journal Article %D 2016 %J ACTA NEUROPHARMACOLOGICA %R 10.3969/j.issn.2095-396.2016.03.004 %P 24-31 %V 6 %N 3 %U {http://actanp.hebeinu.edu.cn/CN/abstract/article_316.shtml} %8 2016-06-26 %X Alzheimer’s disease （AD） is the main type of dementia，accounting for 50%~70% of dementia cases. With the emergence of population aging，the incidence and severity of AD are increasing，which brings great economic burden to families and society and attracts great attention from governments and scholars at home and abroad. Positron emission tomography （PET） can use different tracers for imaging to accurately monitor neuronal activity and brain tissue specific biochemical processes in vivo. Compared with other imaging techniques，PET has a high specificity and sensitivity to early diagnosis of AD. Therefore，it is very important for PET to develop more valuable PET tracers for AD. This paper summarizes the application of PET in the pathology diagnosis and curative effect for AD，and focuses on the role of PET in the early diagnosis and its progress.